Cost-effectiveness analysis of toripalimab combined with nab-paclitaxel as a first-line treatment for advanced TNBC in the US. Chen P, Qiao D, Xiao L, Deng G, et al. PLoS One 2025;20:e0320727.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen P, Qiao D, Xiao L, Deng G, et al. Cost-effectiveness analysis of toripalimab combined with nab-paclitaxel as a first-line treatment for advanced TNBC in the US. PLoS One 2025;20:e0320727.
PMID: 40168440